[go: up one dir, main page]

AU2462895A - Enhancing the sensitivity of tumor cells to therapies - Google Patents

Enhancing the sensitivity of tumor cells to therapies

Info

Publication number
AU2462895A
AU2462895A AU24628/95A AU2462895A AU2462895A AU 2462895 A AU2462895 A AU 2462895A AU 24628/95 A AU24628/95 A AU 24628/95A AU 2462895 A AU2462895 A AU 2462895A AU 2462895 A AU2462895 A AU 2462895A
Authority
AU
Australia
Prior art keywords
therapies
enhancing
sensitivity
tumor cells
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU24628/95A
Other versions
AU697088B2 (en
Inventor
Ruth A. Gjerset
Robert E. Sobol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sidney Kimmel Cancer Center
Original Assignee
San Diego Regional Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by San Diego Regional Cancer Center filed Critical San Diego Regional Cancer Center
Publication of AU2462895A publication Critical patent/AU2462895A/en
Assigned to SIDNEY KIMMEL CANCER CENTER reassignment SIDNEY KIMMEL CANCER CENTER Amend patent request/document other than specification (104) Assignors: SAN DIEGO REGIONAL CANCER CENTER
Application granted granted Critical
Publication of AU697088B2 publication Critical patent/AU697088B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU24628/95A 1994-04-29 1995-04-28 Enhancing the sensitivity of tumor cells to therapies Ceased AU697088B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US23622194A 1994-04-29 1994-04-29
US08/236221 1994-04-29
US24881494A 1994-05-24 1994-05-24
US08/248814 1994-05-24
US33546194A 1994-11-07 1994-11-07
US08/335461 1994-11-07
PCT/US1995/005272 WO1995030002A2 (en) 1994-04-29 1995-04-28 Enhancing the sensitivity of tumor cells to therapies

Publications (2)

Publication Number Publication Date
AU2462895A true AU2462895A (en) 1995-11-29
AU697088B2 AU697088B2 (en) 1998-09-24

Family

ID=27398822

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24628/95A Ceased AU697088B2 (en) 1994-04-29 1995-04-28 Enhancing the sensitivity of tumor cells to therapies

Country Status (6)

Country Link
EP (1) EP0758382A1 (en)
JP (2) JPH09512554A (en)
KR (1) KR970702915A (en)
AU (1) AU697088B2 (en)
CA (1) CA2189032A1 (en)
WO (1) WO1995030002A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) * 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
US6410010B1 (en) 1992-10-13 2002-06-25 Board Of Regents, The University Of Texas System Recombinant P53 adenovirus compositions
AU663702B2 (en) 1991-03-06 1995-10-19 Board Of Regents, The University Of Texas System Methods and compositions for the selective inhibition of gene expression
CN1203632A (en) 1995-07-17 1998-12-30 德克萨斯州立大学董事会 P16 Expression Construct and Its Application in Cancer Therapy
US7163925B1 (en) 1995-07-17 2007-01-16 Board Of Regents, The University Of Texas System p16 expression constructs and their application in cancer therapy
KR20080084528A (en) * 2007-03-15 2008-09-19 제네렉스 바이오테라퓨틱스 인크. Oncolytic Vaccinia Virus Cancer Treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233441T2 (en) * 1991-04-26 2005-10-13 Osaka Bioscience Institute, Suita Human cell surface antigen encoding DNA
EP0615453B1 (en) * 1991-11-29 1997-05-14 Chiron Viagene, Inc. Anti-cancer immunotherapeutic vector constructs
DE69333955D1 (en) * 1992-04-24 2006-02-02 Stanford Res Inst Int TARGETING HOMOLOGOUS SEQUENCES IN EUKARYOTIC CELLS
JPH08504095A (en) * 1992-09-18 1996-05-07 カンジ，インコーポレイテッド Gene therapy with retroviral vector containing tumor suppressor gene

Also Published As

Publication number Publication date
JPH09512554A (en) 1997-12-16
KR970702915A (en) 1997-06-10
JP2007099780A (en) 2007-04-19
AU697088B2 (en) 1998-09-24
WO1995030002A3 (en) 1995-11-30
EP0758382A1 (en) 1997-02-19
WO1995030002A2 (en) 1995-11-09
CA2189032A1 (en) 1995-11-09

Similar Documents

Publication Publication Date Title
AU5141193A (en) Monoclonal antibodies to prostate cells
AU3164493A (en) Improvements in or relating to the lining of passageways
AU3927493A (en) Improved enzyme electrodes
AU2876589A (en) Amphibious backpack
AU3114489A (en) Hammermill
AU3583797A (en) Enhancement of cancer cell death
AU5734694A (en) Pre-amplifier
AU591900B2 (en) Chassis dynamometer construction
AU574363B2 (en) Portable crusher vehicle
AU5564386A (en) Therapeutic particles
AU2462895A (en) Enhancing the sensitivity of tumor cells to therapies
AU3305289A (en) Concentrator
AU2777789A (en) Biosensor
AU1744600A (en) Detection of t cell stimulating tumor antigens
AU4026689A (en) Improved floating point unit computation techniques
AU588900B2 (en) Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones
AU580178B2 (en) Disk crusher
AU9276398A (en) Materials and methods relating to the stimulation of cells
AU9107191A (en) Targetting ige effector cells to tumor cells
AU547166B2 (en) Human leucocyte pepsin-like enzyme
AU3578189A (en) Improved radiotherapy
AU4643185A (en) Wheeled cherry-picker
AU6384486A (en) Cardiotonic aroylthiazolones
AU4056389A (en) Mercapto-acylamino acid antihypertensives
AU2185195A (en) Reperfusion therapy using antibodies to L-selectin